Literature DB >> 1009357

Metronidazole and anaerobic sepsis.

S J Eykyn, I Phillips.   

Abstract

Fifty patients with anaerobic sepsis were treated with intravenous and oral metronidazole. In 26 cases this was combined with other antimicrobial agents. Highly satisfactory clinical results were obtained in most patients, though in many surgical drainage was also essential. No side effects or thrombophlebitis were seen. Mixed growths of anaerobic and aerobic bacteria were isolated from all except five patients, who produced only anaerobes. Metronidazole is the only available antimicrobial agent providing selective activity against anaerobic organisms. It is effective and safe and is usually the drug of choice for treating severe anaerobic sepsis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1009357      PMCID: PMC1690376          DOI: 10.1136/bmj.2.6049.1418

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.

Authors:  H R Ingham; G E Rich; J B Selkon; J H Hale; C M Roxby; M J Betty; R W Johnson; P R Uldall
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

2.  Rapid diagnosis of anaerobic infections by gas-liquid chromatography of clinical material.

Authors:  K D Phillips; P V Tearle; A T Willis
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

3.  Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.

Authors:  I Phillips; C Warren
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Activity of metronidazole against experimental tetanus and gas gangrene.

Authors:  W A Freeman; J A McFadzean; J P Whelan
Journal:  J Appl Bacteriol       Date:  1968-12

5.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

6.  Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial.

Authors:  J Goldring; W McNaught; A Scott; G Gillespie
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

7.  Simplified gas chromatographic procedure for identification of bacterial metabolic products.

Authors:  J Carlsson
Journal:  Appl Microbiol       Date:  1973-02

8.  Metronidazole versus anaerobes. In vitro data and initial clinical observations.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Calif Med       Date:  1972-12
  8 in total
  19 in total

1.  Erythromycin-resistant Clostridium welchii.

Authors:  J G Wallace
Journal:  Br Med J       Date:  1977-02-05

2.  Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.

Authors:  Tingting Ju; Yasmeen Shoblak; Yanhua Gao; Kaiyuan Yang; Janelle Fouhse; B Brett Finlay; Yee Wing So; Paul Stothard; Benjamin P Willing
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

Review 3.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.

Authors:  J A Smith; A G Skidmore; A D Forward; A M Clarke; E Sutherland
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

5.  Diagnosis of anaerobic infection by gas chromatographic estimation of volatile fatty acids.

Authors:  W W Nichols; M R Crow; K Nicholls
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

6.  Plasma metronidazole concentrations after single and repeated vaginal pessary administration.

Authors:  I G Salas-Herrera; M Lawson; A Johnston; P Turner; D M Gott; M J Dennis
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

7.  The penetration of metronidazole into synovial fluid.

Authors:  M A Sattar; M G Sankey; M I Cawley; C M Kaye; J E Holt
Journal:  Postgrad Med J       Date:  1982-01       Impact factor: 2.401

8.  Gas-liquid chromatography in the diagnosis of anaerobic infections: a three year experience.

Authors:  B Watt; P A Geddes; O A Greenan; S K Napier; A Mitchell
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

Review 9.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.